Patient articles
Melanoma articles
Plain-language, evidence-graded explainers built from a curated research corpus. Each article cites peer-reviewed sources and points to specialist follow-up.
immunotherapy
What are checkpoint inhibitors and how do they work in melanoma?
A plain-language guide to checkpoint inhibitor immunotherapy — what immune checkpoints are, how PD-1, CTLA-4, and LAG-3 blockade works, what to expect from treatment, and key questions to ask your specialist.
immunotherapyNivolumab + relatlimab (Opdualag) for advanced melanoma: what patients need to know
A plain-language guide to Opdualag — the dual LAG-3 + PD-1 checkpoint blockade approved in 2022 for first-line advanced melanoma. What the RELATIVITY-047 trial showed, who it is for, how it compares to other immunotherapy combinations, and what side effects to expect.